07630.HK
IMPACT THERAP-B
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 13.03
+15.51%Margins
Gross margin
87.2%
EBITDA margin
-169.9%
EBIT margin
-173.7%
Net margin
-214.3%
FCF margin
-82.6%
-32.1%
Return on equity
-21.6%
Return on assets
-25.9%
Return on invested capital
0.16x
Asset turnover
-HKD 110.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026